CMMB
Chemomab Therapeutics
CMMB
CMMB
12 hedge funds and large institutions have $58.7M invested in Chemomab Therapeutics in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.53M | |
| 2 | +$1.21M | |
| 3 | +$837K | |
| 4 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$615K |
| 5 |
VF
Virtu Financial
New York
|
+$251K |
Top Sellers
| 1 | -$3.63M | |
| 2 | -$2.69M | |
| 3 | -$202K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$134K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$14.9K |